Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa3g01767 | ATGAAACTTTTTCTTTTCTTTCTCATCACATTCTCTTTCTTTTTCCAAACACAGTTACCACTAGTTTCTTCTGCTACAACTCTTCCCTTTCAACTCATCACTCTCCTCTCAATAAAATCAGCCCTCATTGACCCTCTCAATCATCTCAGTGACTGGAAAATCAACCCTTCTAATTCTTCCTCTACTTTCTCAAACTCCAATAACTCCCAAAACCCAATTTGGTGTTTTTGGAGAGGCATCACTTGTCACCCAAAAACAGCACAAATCACTTCACTAAACCTTTCTCACCTCAATCTTTCAGGCACAATCTCACCTCAAATCCGCTACTTAACCACCTTAACCCACTTGAACATAAGTGGAAATGATTTCAATGGAACTTTTCAAACAGCAATTTTCCAACTCACTGAGCTTAGAACACTAGACATTAGCCATAACTCCTTCAACTCAACTTTCCCACCTGGAATATCAAAGTTAAGATTCTTAAGAATCTTCAATGCTTACAGCAACAACTTCACAGGCCCTCTTCCTGAAGAACTAATCAGGCTTCCATTTCTAGAACAACTTAACCTTGGTGGAAGCTATTTCAGTGGCAGAATCCCACCAAGCTATGGAACTTTCAAAAGACTCAAATTCCTATTATTTCATGGTAATGAATTGGAAGGTTCACTACCACCTGAATTAGGCTTATTATCAGAGCTACAACACTTGGAAATTGGATACAACCCATTCTCAGGAACAATACCAGTGGAATTAACAATGTTGTCTAATCTCAAATACTTAGACATCTCATTCACAAACATCTCAGGTCAAGTGATTCCTGGACTAGGAAACTTAACCATGCTTGAAAATTTGTTTCTCTTTGGAAATCGGTTAAGCGGAGAAATCCCATCAAGCATAGGCAAGTTGAAATCGCTAAAAGATCTTGATTTATCAGACAATGAACTCACAGGTTCAATTCCACCAGAAATAACAATGTTGAAGGAACTAACAAGGATGAATCTTATGATTAACAAGCTAAAAGGTGAAATTCCACAAGGAATTGGCGAGCTGCCAAATCTCAACAGGTTCTATGTTTTCAACAACTCGCTCAATGGTACACTGCCACCAAAACTCGGCTCCAACGGGCTACTACAATTACTAGATGTTTCCACAAACTCACTTCAAGGTCCAATCCCTATGAACATTTGCAAGGGAAACAATCTTGTTAAGTTCAATCTCTTTGACAACAAATTCACCAATATTCTTCCATTATCACTCACTAAATGCACCTCACTTGCTCGGGTTCGGATACAAAACAACAAACTCACAGGTTCAATTCCACAAACACTTACAATGCTTCCTAATTTGACATACCTTGATTTGAGCAACAACAATTTCTACGGGGAAATTCCTAAAGAATTAGGCAATCTCCAATACCTAAACATCACAGGAAACTCGTTTGAAAGCAATTTACCTAGCAACATTTGGAACGCAAGTAATCTACAGATTTTCTCAGCTTCGAGTTCAAAAATCACTGGTCAAATTCCCGAATTCGTTGGATGCGACTCGATTTACAAGATCGAATTGCAAGGGAATTTAATCAACGGTAGCATTCCTTGGAATATCGGTCACTGCGAGAAACTGATTATGTTGAACCTAAGTAGAAACAATCTCACCGGAATCATACCTTGGGAAATCTCAACTCTTCCTTCAATCACCGACGTTGATCTCTCACAAAACTCACTCACCGGAACAATACCTTCAAGCTTCAACAATTGCTCCACTCTCCAGAATTTCAACGTCAGCTTCAACTTCCTCACCGGTCCAATTCCTTCCTCAGGCATCTTCCAAAGTCTCCATCCTTCTTCCTACTCTGGCAACAAAAACCTCTGCGGTGATCTTCTAGCCAAACCATGTGCCTCCGCCGGAGAAAACGAACTAGAGGTCTACCACCAGGAACCGAAGAAAACCGCGGGCGCAATCATTTGGATAATCGCGGCAGCGTTCGGGATCGGACTCTTCGTTATCGTCGCCGGAACACGTTGCTTCCACGCGAATTATAAGCGTGGTTTCAACGAGAGCAACGGCGAAATCGGACCGTGGAAGTTAACGGCGTTTCAGCGGTTAAATTTCACGGCGGATGATGTACTCGAGTGCGTTTCAATGTCAGATAAGATATTAGGAATGGGGTCCACAGGAACGGTTTATAAAGCGGAAATGCCAGGTGGAGAAATCATAGCCGTTAAAAAGCTTTGGGGAAAACAAAAGGAAAATAACAGTAATCTAATCCGACGGAGGAGAGGCGTTTTAGCTGAAGTGGATGTATTAGGAACCGTGAGACACAGGAATATTGTGAGATTGTTAGGCTGTTGCAGCAATCAGGAAATTACCATGTTGCTCTACGAGTACATGCCAAATGGTAACCTTGATGATTTGTTACATGGAGAGAATAAAGGGGACAATATGGTAATTTCGGATTGGTTAACTAGGTATAAGATAGCATTGGGTGTGGCTCAGGGGATATGTTATCTACACCATGATTGTGATCCTGTGATTGTGCATAGAGATCTTAAACCTAGTAACATTTTATTGGACGGTGAGATGGAAGCTAGAGTGGCTGATTTTGGTGTTGCTAAGTTGATTCAAGCTGATGAATCTATGTCTGTTATTGCTGGATCATATGGTTACATTGCTCCAGAGTATGCTTATACACTCCAAGTTGATGAGAAGAGTGATATATACAGTTATGGAGTGGTGTTGATGGAGATTTTAAGTGGAAAACGTTCTGTGGATCAAGAATTTGGTGATGGGAATAGTATTGTGGATTGGGTTAAGTCGAAAGTAAAGACGAAAGATGGAGTTGAAGGTATATTGGACAAGAATGCAGGGCCAGGGTGTGGTTCAGTGAAAGAAGAAATGATACAGATGCTTAGAATTGCATTGCTTTGTACAAGTAGAAATCCAGCTGATAGGCCTTCAATGAGAGATGTTGTGTTGATGCTTCAAGCTGCTAAACCTAAGAGGAAATTGCTTGGTGGAGGTGGTGATGTTGCTTTGATTCAAAAGCCAGTTACCAATGAAAGCTAG | 3066 | 0.4077 | MKLFLFFLITFSFFFQTQLPLVSSATTLPFQLITLLSIKSALIDPLNHLSDWKINPSNSSSTFSNSNNSQNPIWCFWRGITCHPKTAQITSLNLSHLNLSGTISPQIRYLTTLTHLNISGNDFNGTFQTAIFQLTELRTLDISHNSFNSTFPPGISKLRFLRIFNAYSNNFTGPLPEELIRLPFLEQLNLGGSYFSGRIPPSYGTFKRLKFLLFHGNELEGSLPPELGLLSELQHLEIGYNPFSGTIPVELTMLSNLKYLDISFTNISGQVIPGLGNLTMLENLFLFGNRLSGEIPSSIGKLKSLKDLDLSDNELTGSIPPEITMLKELTRMNLMINKLKGEIPQGIGELPNLNRFYVFNNSLNGTLPPKLGSNGLLQLLDVSTNSLQGPIPMNICKGNNLVKFNLFDNKFTNILPLSLTKCTSLARVRIQNNKLTGSIPQTLTMLPNLTYLDLSNNNFYGEIPKELGNLQYLNITGNSFESNLPSNIWNASNLQIFSASSSKITGQIPEFVGCDSIYKIELQGNLINGSIPWNIGHCEKLIMLNLSRNNLTGIIPWEISTLPSITDVDLSQNSLTGTIPSSFNNCSTLQNFNVSFNFLTGPIPSSGIFQSLHPSSYSGNKNLCGDLLAKPCASAGENELEVYHQEPKKTAGAIIWIIAAAFGIGLFVIVAGTRCFHANYKRGFNESNGEIGPWKLTAFQRLNFTADDVLECVSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKQKENNSNLIRRRRGVLAEVDVLGTVRHRNIVRLLGCCSNQEITMLLYEYMPNGNLDDLLHGENKGDNMVISDWLTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQADESMSVIAGSYGYIAPEYAYTLQVDEKSDIYSYGVVLMEILSGKRSVDQEFGDGNSIVDWVKSKVKTKDGVEGILDKNAGPGCGSVKEEMIQMLRIALLCTSRNPADRPSMRDVVLMLQAAKPKRKLLGGGGDVALIQKPVTNES | 1021 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa3g01767 | 1021 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 845 | 857 | IPR008271 | GO:0004672|GO:0006468 | |
Vifa3g01767 | 1021 | ProSiteProfiles | Leucine-rich repeat profile. | 304 | 326 | IPR001611 | GO:0005515 | |
Vifa3g01767 | 1021 | Gene3D | Transferase(Phosphotransferase) domain 1 | 797 | 1004 | - | - | |
Vifa3g01767 | 1021 | FunFam | leucine-rich repeat receptor-like protein kinase TDR | 797 | 1005 | - | - | |
Vifa3g01767 | 1021 | ProSitePatterns | Protein kinases ATP-binding region signature. | 720 | 743 | IPR017441 | GO:0005524 | |
Vifa3g01767 | 1021 | SUPERFAMILY | RNI-like | 91 | 412 | - | - | |
Vifa3g01767 | 1021 | Pfam | Leucine Rich Repeat | 448 | 470 | IPR001611 | GO:0005515 | |
Vifa3g01767 | 1021 | ProSiteProfiles | Protein kinase domain profile. | 714 | 1004 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa3g01767 | 1021 | SUPERFAMILY | Protein kinase-like (PK-like) | 717 | 994 | IPR011009 | - | |
Vifa3g01767 | 1021 | PRINTS | Leucine-rich repeat signature | 305 | 318 | - | - | |
Vifa3g01767 | 1021 | PRINTS | Leucine-rich repeat signature | 446 | 459 | - | - | |
Vifa3g01767 | 1021 | PANTHER | LEUCINE RICH REPEAT FAMILY PROTEIN, EXPRESSED | 266 | 996 | - | - | |
Vifa3g01767 | 1021 | SMART | serkin_6 | 714 | 996 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa3g01767 | 1021 | Gene3D | Ribonuclease Inhibitor | 164 | 269 | IPR032675 | - | |
Vifa3g01767 | 1021 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 | 683 | 796 | - | - | |
Vifa3g01767 | 1021 | Gene3D | Phosphorylase Kinase; domain 1 | 695 | 796 | - | - | |
Vifa3g01767 | 1021 | Gene3D | Ribonuclease Inhibitor | 270 | 328 | IPR032675 | - | |
Vifa3g01767 | 1021 | Gene3D | Ribonuclease Inhibitor | 32 | 160 | IPR032675 | - | |
Vifa3g01767 | 1021 | SUPERFAMILY | L domain-like | 319 | 624 | - | - | |
Vifa3g01767 | 1021 | FunFam | Leucine-rich repeat receptor-like protein kinase TDR | 326 | 634 | - | - | |
Vifa3g01767 | 1021 | Pfam | Protein kinase domain | 717 | 991 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa3g01767 | 1021 | Pfam | Leucine rich repeat | 517 | 575 | IPR001611 | GO:0005515 | |
Vifa3g01767 | 1021 | Gene3D | Ribonuclease Inhibitor | 337 | 640 | IPR032675 | - | |
Vifa3g01767 | 1021 | SMART | LRR_typ_2 | 446 | 470 | IPR003591 | - | |
Vifa3g01767 | 1021 | SMART | LRR_typ_2 | 134 | 158 | IPR003591 | - | |
Vifa3g01767 | 1021 | SMART | LRR_typ_2 | 562 | 585 | IPR003591 | - | |
Vifa3g01767 | 1021 | SMART | LRR_typ_2 | 302 | 326 | IPR003591 | - | |
Vifa3g01767 | 1021 | SMART | LRR_typ_2 | 350 | 374 | IPR003591 | - | |
Vifa3g01767 | 1021 | FunFam | LRR receptor-like serine/threonine-protein kinase GSO1 | 82 | 274 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa3g01767 | Vifa-Chr3 | 463349567 | 463353138 | Dispersed/Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa3g01767 | 3 | 1002 | Receptor kinase-like Gene Family | AT1G08590 | 43.093 | 0.0 | 754 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Vifa3g01767 | Pkinase | 1.4e-47 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa3g01767 | - | - | gmx:100813189 | 1539.63 |